yttrium has been researched along with (dtpa-phe(1))-octreotide in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Buchsbaum, DJ; Chaudhuri, TR; Lin, CY; Rogers, BE; Zinn, KR | 1 |
1 other study(ies) available for yttrium and (dtpa-phe(1))-octreotide
Article | Year |
---|---|
Targeted radiotherapy with [(90)Y]-SMT 487 in mice bearing human nonsmall cell lung tumor xenografts induced to express human somatostatin receptor subtype 2 with an adenoviral vector.
Topics: Adenoviridae; Animals; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Disease Models, Animal; Drug Delivery Systems; Genetic Vectors; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Octreotide; Pentetic Acid; Radioimmunodetection; Radiotherapy; Receptors, Somatostatin; Somatostatin; Treatment Outcome; Tumor Cells, Cultured; Xenograft Model Antitumor Assays; Yttrium | 2002 |